US Patent 7605239 Skeletal-targeted radiation to treat bone-associated pathologies
Patent 7605239 was granted and assigned to Poniard Pharmaceuticals, Inc. on October, 2009 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 22, 2006
Date of Patent
October 20, 2009
Patent Application Number
11359744
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7605239 Skeletal-targeted radiation to treat bone-associated pathologies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
